Trial Profile

A First-In-Human, Single Centre, Randomised, Double-Blind, Placebo-Controlled Study to Investigate Recombinant BoNT Serotype E (rBoNT-E) in Healthy Male Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 29 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Botulinum toxin E (Primary) ; Botulinum-Toxin-A
Indications Glabellar lines; Muscle spasticity
Focus Adverse reactions; First in man
Sponsors Ipsen

Most Recent Events

23 Jan 2019 According to an Ipsen media release, results of this study are being presented at the TOXINS International Conference in Copenhagen (2019).
23 Jan 2019 New trial record
17 Jan 2019 Results presented in an Ipsen media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com